Isoray To Announce Fourth Quarter and Fiscal Year End 2022 Financial Results on September 28, 2022
Isoray (NYSE AMERICAN: ISR) will host a conference call on September 28, 2022, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year ending June 30, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Isoray (NYSE AMERICAN: ISR) will host a conference call on September 28, 2022, at 4:30 p.m. ET to discuss its financial results for the fourth quarter and fiscal year ending June 30, 2022. A press release detailing these results will be issued after U.S. market close on the same day. Interested parties can join the call by dialing 888-506-0062 (973-528-0011 for international calls) or via a webcast that will remain available until December 28, 2022. Isoray specializes in Cesium-131 brachytherapy seeds for cancer treatment.
Details
News Market Reaction – ISR
The recorded move for ISR in the trading session of this news was -6.65%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Conference Call is Wednesday, September 28 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, Wash., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy, today announced that it will host a conference call to discuss its financial results for the fourth quarter and fiscal year ended June 30, 2022 on Wednesday, September 28, 2022, at 4:30 p.m. Eastern Time. The Company will issue a press release announcing its financial results for the fourth quarter and fiscal year ended June 30, 2022 after the close of the U.S. stock markets on September 28, 2022.
To listen to the conference call, please dial 888-506-0062. For callers outside the U.S., please dial 973-528-0011.
The conference call will be simultaneously webcast and can be accessed at https://www.webcaster4.com/Webcast/Page/2199/46490. The webcast will be available until December 28, 2022 following the conference call.
About Isoray
Isoray, Inc. is a medical technology company pioneering advanced treatment applications and devices to deliver targeted internal radiation treatments for cancers throughout the body. Isoray, Inc., through its subsidiary, Isoray Medical, Inc., is the sole producer of Cesium-131 brachytherapy seeds. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us on LinkedIn and Twitter.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.